Hospital Alvaro Cunqueiro | ClinicalTrials HQ

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis	Active, not recruiting	Phase 3	2026-09-28		NCT04544436
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma	Blood Protein Disorders, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Gaucher disease, Hemic and Lymphatic Diseases, Hypertrophy, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Neoplasms by Histologic Type, Niemann-Pick disease, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Splenomegaly, brain disorder, cardiovascular disorder, central nervous system disorder, hematologic disorder, hemorrhagic disease, hereditary disease, histiocytosis, immune system disorder, immunoproliferative disorder, inborn errors of metabolism, lymphatic system disorder, lymphoproliferative syndrome, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, monoclonal gammopathy, neoplasm, nervous system disorder, non-Langerhans cell histiocytosis, plasma cell neoplasm, sphingolipidosis, vascular disorder, vascular hemostatic disease	Recruiting	Not stated	2026-02-11		NCT05992532